The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
Status:
RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The study aims to improve the safety of the electroporation ablation (PFA) procedure by using muscle relaxants to reduce skeletal muscle damage during the procedure. It will also assess myocardial damage to improve the procedure's quality and speed up recovery after the procedure.
Phase:
NA
Details
Lead Sponsor:
4th Military Clinical Hospital with Polyclinic, Poland